Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice

Fig. 4

18F-FDG PET showing an extended area of disomogeneous abnormal hypermetabolism at the level of mass of the rectum, with both endoluminal and extraluminal expansion. Coronal plain (a), axial plain (b) and axial PET/CT (c). Pathologic hypermethabolism was confirmed at the level of the subcutaneous nodule of the right lumbar region (d, axial PET. e, axial PET/CT)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us